AD/PD 2024

AD/PD™ is a conference focuses on basic science and translational and clinical research to bring you the latest findings from clinical trials, somes new insights on disease mechanisms and etiologies or advances in diagnostic markers for example.

The AD/PD™ conference has become one of the must-attend events in the field of neurodegenerative disorders, with over 4,100 participants from 61 countries and more than 2,000 abstracts in 2023.

SynapCell will be presenting new data in a Poster (P0852) on the “Characterization of a Transgenic Mouse Model of Tauopathy Using Quantitative EEG: Does Tau Pathology Lead to Disrupted Spectra?”

We look forward to discussing with you there !